ASTH

#1955
Astrana Health Inc. - Common Stock
37.7 7 USD
-0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
37.77
38.19
Intervallo Annuale
18.08
51.59
Variazione giornaliera
-0.50%
Variazione Mensile
+6.33%
Variazione di 6 mesi
+57.11%
Variazione Annuale
+19.07%
Chiusura Precedente
37.9 6
Open
38.1 5
Minimo
37.7 7
Massimo
38.1 9
Volume
44
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
Astrana Health, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Astrana Health, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Astrana Health, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Astrana Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Astrana Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Astrana Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Astrana Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Astrana Health, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2025
Astrana Health, Inc. quarterly report, Q1 FY2025
10-Q
Current report, Q1 FY2026
Astrana Health, Inc. current report, Q1 FY2026
8-K

Astrana Health, Inc. current report, Q1 FY2025

Full document

Astrana Health, Inc. (ASTH) - Form 8-K Summary

Business Context and Reporting Period

Company: Astrana Health, Inc.
Filing Date: March 3, 2025
Reporting Period: Current Report (Event Date: March 3, 2025)
Business Overview: The Company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC under the symbol "ASTH".

Financial Metrics

This filing is a Current Report on Form 8-K regarding Regulation FD disclosure and does not contain audited or unaudited financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics.

Material Changes

The primary event reported is the update of the Company's corporate presentation materials intended for use at conferences and meetings. No material changes to financial performance or operational status are detailed in this specific document.

Guidance, Outlook, and Risks

  • Disclosure: The Company updated its investor presentation (attached as Exhibit 99.1) to reflect current information.
  • Forward-Looking Statements: The filing contains forward-looking statements regarding forecasts, guidance, and estimates. These are subject to risks and uncertainties that could cause actual results to differ materially.
  • Limitations: The Company explicitly states it does not undertake any responsibility to update the information in the attached presentation or to announce revisions to forward-looking statements.
  • Legal Status: The information furnished is not deemed "filed" under Section 18 of the Exchange Act and shall not be incorporated by reference into other filings.

Key Facts for Investor Verification

  • Verify the content of the updated Investor Presentation (Exhibit 99.1) for specific strategic or operational updates not detailed in the 8-K text.
  • Review the most recent Form 10-K and Form 10-Q filings for actual financial performance data, as this 8-K contains no financial figures.
  • Note that the Company has disclaimed any obligation to update the forward-looking statements contained in the attached presentation.

Notizie